Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET
Company Participants
Todd Friedman - Senior Director of Investor Relations
Christian Henry - President and Chief Executive Officer
Susan Kim - Chief Financial Officer
Conference Call Participants
Tejas Savant - Morgan Stanley
Kyle Nixon - Canaccord
Mason Carrico - Stephens
Dan Brennan - TD Cowen
Jack Meehan - Nephron Research
Subbu Nambi - Guggenheim Securities
Madeline Mollman - Wolfe Research
Operator
Good day and welcome to the PacBio Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Todd Friedman, Senior Director of Investor Relations. Please go ahead.
Todd Friedman
Good afternoon, and welcome to PacBio's third quarter 2024 earnings conference call. Earlier today, we issued a press release outlining the financial results, we will be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com or as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov. A copy of our earnings presentation is also available on the Investor section of our website.
With me today are Christian Henry, President and Chief Executive Officer; and Susan Kim, Chief Financial Officer.
On today's call, we will be making forward-looking statements, including among other statements regarding predictions, estimates, expectations and guidance. You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks, and uncertainties that could cause our actual results to differ materially from those projected or discussed.
Please review our SEC filing including our most recent Forms 10-Q and 10-K, and our press release to better understand the risks and uncertainties that could cause results to differ. We disclaim any obligation to update or revise these forward-looking statements except as required by law.
We will also present certain financial information on a non-GAAP basis which is not prepared under a comprehensive set of accounting rules and should only be used to supplement in understanding of the Company's operating results as reported under U.S. GAAP.
Reconciliations between historical U.S. GAAP and non-GAAP results are presented our press release which is available on the investors section of our website. For future periods, we are unable to reconcile non-GAAP gross margin and non-GAAP operating expenses without unreasonable efforts due to the uncertainty regarding, among other matters, certain acquisition-related items that may arise during the year.